Education
About Us
Working with TipRanks
Follow Us
Inspire Medical (INSP)
:INSP
INSP Analyst Ratings
Moderate Buy
10 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
INSP Stock 12 Month Forecast
Average Price Target
$169.60
▲(30.51% Upside)
| Highest Price Target$255.00 | Average Price Target$169.60 | Lowest Price Target$116.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$82
Hold
-36.90%
Downside
Downgraded
08/07/25
Inspire Medical Systems' overall stock score is driven by strong financial performance and promising corporate developments. However, technical analysis indicates bearish momentum, and valuation metrics suggest the stock is overvalued. Mixed sentiment from the earnings call, with reduced guidance, also impacts the score.
Truist Financial
$190→$125
Hold
-3.81%
Downside
Downgraded
08/05/25
Piper Sandler
$233→$150
Buy
15.43%
Upside
Reiterated
08/05/25
Nephron
$130
Hold
0.04%
Upside
Downgraded
08/05/25
Mizuho Securities
$215→$170
Buy
30.82%
Upside
Reiterated
08/05/25
Robert W. Baird
$236→$150
Buy
15.43%
Upside
Reiterated
08/05/25
Stifel Nicolaus
$175→$140
Hold
7.73%
Upside
Reiterated
08/05/25
Leerink Partners
$149→$116
Hold
-10.73%
Downside
Reiterated
08/05/25
UBS
$270→$230
Buy
76.99%
Upside
Reiterated
08/05/25
Lake Street
$270→$150
Buy
15.43%
Upside
Reiterated
08/05/25
Jefferies
$205→$160
Buy
23.12%
Upside
Reiterated
08/05/25
KeyBanc
$216→$197
Buy
51.60%
Upside
Reiterated
07/22/25
Morgan Stanley
$200→$182
Buy
40.05%
Upside
Reiterated
07/15/25
RBC Capital
$215
Buy
65.45%
Upside
Reiterated
07/15/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$82
Hold
-36.90%
Downside
Downgraded
08/07/25
Inspire Medical Systems' overall stock score is driven by strong financial performance and promising corporate developments. However, technical analysis indicates bearish momentum, and valuation metrics suggest the stock is overvalued. Mixed sentiment from the earnings call, with reduced guidance, also impacts the score.
Truist Financial
$190→$125
Hold
-3.81%
Downside
Downgraded
08/05/25
Piper Sandler
$233→$150
Buy
15.43%
Upside
Reiterated
08/05/25
Nephron
$130
Hold
0.04%
Upside
Downgraded
08/05/25
Mizuho Securities
$215→$170
Buy
30.82%
Upside
Reiterated
08/05/25
Robert W. Baird
$236→$150
Buy
15.43%
Upside
Reiterated
08/05/25
Stifel Nicolaus
$175→$140
Hold
7.73%
Upside
Reiterated
08/05/25
Leerink Partners
$149→$116
Hold
-10.73%
Downside
Reiterated
08/05/25
UBS
$270→$230
Buy
76.99%
Upside
Reiterated
08/05/25
Lake Street
$270→$150
Buy
15.43%
Upside
Reiterated
08/05/25
Jefferies
$205→$160
Buy
23.12%
Upside
Reiterated
08/05/25
KeyBanc
$216→$197
Buy
51.60%
Upside
Reiterated
07/22/25
Morgan Stanley
$200→$182
Buy
40.05%
Upside
Reiterated
07/15/25
RBC Capital
$215
Buy
65.45%
Upside
Reiterated
07/15/25
Best Analysts Covering Inspire Medical Systems
1 Month
xxx
Success Rate
12/22 ratings generated profit
Average Return
+2.71%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 54.55% of your transactions generating a profit, with an average return of +2.71% per trade.
3 Months
xxx
Success Rate
14/22 ratings generated profit
Average Return
+11.23%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 63.64% of your transactions generating a profit, with an average return of +11.23% per trade.
1 Year
Success Rate
15/33 ratings generated profit
Average Return
+8.65%
reiterated a buy rating 3 days ago
Copying Adam Maeder's trades and holding each position for 1 Year would result in 46.88% of your transactions generating a profit, with an average return of +8.65% per trade.
2 Years
xxx
Success Rate
13/32 ratings generated profit
Average Return
+7.29%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 40.63% of your transactions generating a profit, with an average return of +7.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
INSP Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
1
3
7
8
14
Buy
24
17
16
12
2
Hold
5
6
7
7
10
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
26
30
27
26
Each month's total comprises the sum of three months' worth of ratings.
INSP Financial Forecast
INSP Stock Forecast FAQ
What is INSP’s average 12-month price target, according to analysts?
Based on analyst ratings, Inspire Medical’s 12-month average price target is 169.60.
What is INSP’s upside potential, based on the analysts’ average price target?
Inspire Medical has 30.51% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is INSP a Buy, Sell or Hold?
Inspire Medical has a consensus rating of Moderate Buy which is based on 10 buy ratings, 6 hold ratings and 0 sell ratings.
What is Inspire Medical’s price target?
The average price target for Inspire Medical is 169.60. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $255.00 ,the lowest forecast is $116.00. The average price target represents 30.51% Increase from the current price of $129.95.
The highest analyst price target is $255.00 ,the lowest forecast is $116.00. The average price target represents 30.51% Increase from the current price of $129.95.
What do analysts say about Inspire Medical?
Inspire Medical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Streets Analysts.
How can I buy shares of INSP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.